PBS listing of blinatumomab extended
Australians with ALL and minimal residual disease (MRD) can now access blinatumomab on the PBS.
- Acute lymphoblastic leukaemia
- Treatments and side-effects
Australians with ALL and minimal residual disease (MRD) can now access blinatumomab on the PBS.
Lisa Christie shares her experience of having a stem cell transplant following her diagnosis with AML.
Read about the benefits of choosing a generic brand of imatinib.
Asciminib, is the biggest breakthrough in CML treatment this century.
Haematologist Dr David Yeung answers FAQs about generic imatinib.
The aim of the HOVON 150 trial* is to recruit 968 patients from Europe, Australia and other participating countries.
Matt travels to the U.S. every 12 weeks for his hairy cell leukaemia treatment.
When Deyan Cashmere relapsed after a stem cell transplant, his only option was to go to the U.S. for potentially life-saving immunotherapy.